<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7905558</journal-id>
<journal-id journal-id-type="pubmed-jr-id">5306</journal-id>
<journal-id journal-id-type="nlm-ta">J Neurosci Methods</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurosci. Methods</journal-id>
<journal-title-group>
<journal-title>Journal of neuroscience methods</journal-title>
</journal-title-group>
<issn pub-type="ppub">0165-0270</issn>
<issn pub-type="epub">1872-678X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31265868</article-id>
<article-id pub-id-type="pmc">6686874</article-id>
<article-id pub-id-type="doi">10.1016/j.jneumeth.2019.108315</article-id>
<article-id pub-id-type="manuscript">NIHMS1533966</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A More Efficient Conditional Mouse Model of Dravet Syndrome: Implications for Epigenetic Selection and Sex-Dependent Behaviors</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Williams</surname>
<given-names>Aaron D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kalume</surname>
<given-names>Franck</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Westenbroek</surname>
<given-names>Ruth E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Catterall</surname>
<given-names>William A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Departments of Pharmacology, University of Washington, Seattle, Washington, USA.</aff>
<aff id="A2"><label>2</label>Neurological Surgery, University of Washington, Seattle, Washington, USA.</aff>
<aff id="A3"><label>3</label>Center for Integrative Brain Research, Seattle Children’s Research Institute, Seattle, Washington, USA.</aff>
<aff id="A4"><label>4</label>Present address: Xenon Pharmaceuticals, 3650 Gilmore Way, Burnaby BC, Canada</aff>
<author-notes>
<corresp id="CR1">CORRESPONDING AUTHOR: William A. Catterall, <email>wcatt@uw.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>24</day>
<month>7</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>29</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<day>01</day>
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>9</month>
<year>2020</year>
</pub-date>
<volume>325</volume>
<fpage>108315</fpage>
<lpage>108315</lpage>
<!--elocation-id from pubmed: 10.1016/j.jneumeth.2019.108315-->
<abstract id="ABS1">
<sec id="S1">
<title>Background</title>
<p id="P1">Dravet Syndrome (DS) is an epileptic disorder characterized by spontaneous and thermally-induced seizures, hyperactivity, cognitive deficits, autistic-like behaviors, and Sudden Unexpected Death in Epilepsy (SUDEP). DS is caused by <italic>de novo</italic> loss-of-function mutations in the <italic>SCN1A</italic> gene. Selective loss of GABAergic interneuron excitability is the primary cause of the disease. Up to 60% of <italic>Scn1a</italic><sup>+/−</sup> mice die from SUDEP before sexual maturity.</p>
</sec>
<sec id="S2">
<title>New Method</title>
<p id="P2">We used Cre-Lox technology to conditionally delete <italic>Scn1a</italic> in all epiblast-derived somatic cells by crossing a floxed <italic>Scn1a</italic> mouse with a mouse expressing Cre under the <italic>Meox2</italic> promoter.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">Parental <italic>Scn1a flox</italic> (F) mice, parental <italic>Meox2</italic> Cre<sup>+</sup> mice, and their F/+:<italic>Meox2</italic>-Cre<sup>−</sup> offspring were phenotypically normal and did not prematurely die. In contrast, F/+:<italic>Meox2</italic>-Cre<sup>+</sup> offspring recapitulated DS seizure and behavioral phenotypes. Unexpectedly, male F/+:<italic>Meox2</italic>-Cre<sup>+</sup> mice demonstrated impaired social interaction, while females did not.</p>
</sec>
<sec id="S4">
<title>Comparison with Existing Method</title>
<p id="P4">In the previous models, colony maintenance required breeding SUDEP survivors, which greatly increased colony size required to sustain experimental animal production, and raised the concern that surviving breeders have epigenetic traits that impart new phenotypes to their offspring. Our method greatly facilitates breeding, recapitulates DS phenotypes, eliminates concerns about parents that are survivors, and provides initial evidence for unexpected sex-dependent social interaction impairment.</p>
</sec>
<sec id="S5">
<title>Conclusions</title>
<p id="P5">We introduce a more efficient mouse model of human DS that demonstrates an efficient breeding strategy free from potential inherited epigenetic changes and reveals an unexpected sex-specific impairment of social interaction in DS. This new model should have great value to investigators of DS.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Autism</kwd>
<kwd>Dravet Syndrome</kwd>
<kwd>Epilepsy</kwd>
<kwd>Interneuron</kwd>
<kwd>Na<sub>v</sub>1.1</kwd>
<kwd>Sex differences</kwd>
<kwd>Sodium channels</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>